Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Eur J Neurol. 2018 Sep 16;26(1):58–65. doi: 10.1111/ene.13763

Table 1:

Description of characteristics of the US and UK Myotonic Dystrophy Type 1 (DM1) study participants.

US Cohort UK Cohort
Number of Participants with DM1 208 189
Age at Interview;(years; Median
(IQR))*
53 (18.0) 47 (19.5)
DM Inheritance:
Maternal 47 (23%) 35 (19%)
Paternal 71 (34%) 83 (44%)
Unknown 90 (43%) 71 (38%)
Age at Onset (years; Median
(IQR))*
25.5 (23.0) 27.0 (20.5)
Age at Diagnosis (years; Median
(IQR))*
33.0 (23) 33.0 (18)
Sex (% Female) 115 (55%) 98 (52%)
Personal History of Cancer (n/%
Yes)
62 (30%) 11 (6%)
Personal History of benign
Tumor(n/% Yes)
34 (16%) 17 (9%)
Number of Children:
0 99 (48%) 106 (56%)
1 34 (16%) 28 (15%)
2 42 (20%) 37 (20%)
≥3 32 (15%) 18 (10%)
Number of Siblings:
0 18 (9%) 41 (22%)
1 62 (30%) 73 (39%)
2 58 (28%) 52 (28%)
3 35 (17%) 9 (5%)
≥4 35 (17%) 7 (4%)
*

IQR: inter-quartile range; defined as the difference between the 75th and 25th percentiles of the observed quantity.